95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.09%
Revenue growth at 50-75% of AEM's 4.66%. Martin Whitman would worry about competitiveness or product relevance.
6.25%
Gross profit growth under 50% of AEM's 14.73%. Michael Burry would be concerned about a severe competitive disadvantage.
4.11%
EBIT growth 50-75% of AEM's 6.30%. Martin Whitman would suspect suboptimal resource allocation.
4.11%
Operating income growth at 50-75% of AEM's 6.30%. Martin Whitman would doubt the firm’s ability to compete efficiently.
26.42%
Net income growth 1.25-1.5x AEM's 21.11%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
25.93%
EPS growth 1.25-1.5x AEM's 18.95%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
25.93%
Diluted EPS growth 1.25-1.5x AEM's 20.21%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
0.05%
Share reduction more than 1.5x AEM's 0.31%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.04%
Diluted share reduction more than 1.5x AEM's 0.33%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-49.72%
Dividend reduction while AEM stands at 7.49%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
8.76%
OCF growth at 50-75% of AEM's 13.44%. Martin Whitman would question if the firm lags in monetizing sales effectively.
20.73%
FCF growth above 1.5x AEM's 11.46%. David Dodd would verify if the firm’s strategic investments yield superior returns.
46.83%
10Y revenue/share CAGR under 50% of AEM's 95.46%. Michael Burry would suspect a lasting competitive disadvantage.
35.78%
5Y revenue/share CAGR at 50-75% of AEM's 51.36%. Martin Whitman would worry about a lagging mid-term growth trajectory.
13.77%
3Y revenue/share CAGR above 1.5x AEM's 8.62%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
66.91%
10Y OCF/share CAGR under 50% of AEM's 537.18%. Michael Burry would worry about a persistent underperformance in cash creation.
76.04%
5Y OCF/share CAGR above 1.5x AEM's 48.36%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
25.43%
3Y OCF/share CAGR under 50% of AEM's 82.26%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
2617.04%
Net income/share CAGR above 1.5x AEM's 1683.30% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
100.51%
Below 50% of AEM's 254.74%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
13.76%
Below 50% of AEM's 134.00%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
59.30%
10Y equity/share CAGR at 50-75% of AEM's 115.30%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
37.47%
Below 50% of AEM's 104.01%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
20.03%
Below 50% of AEM's 69.38%. Michael Burry suspects a serious short-term disadvantage in building book value.
208.45%
10Y dividend/share CAGR at 50-75% of AEM's 407.36%. Martin Whitman suspects the firm lags in returning cash to shareholders over the decade.
111.38%
Below 50% of AEM's 283.24%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
21.38%
3Y dividend/share CAGR at 50-75% of AEM's 31.45%. Martin Whitman might see a weaker short-term approach to distributing cash.
35.90%
Our AR growth while AEM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
100.00%
Inventory growth well above AEM's 12.92%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.90%
Asset growth 1.25-1.5x AEM's 1.65%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
1.34%
50-75% of AEM's 2.01%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-1.26%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
15.27%
We expand SG&A while AEM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.